Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13950)
All Articles published online
|
Publishing Process of This Article
|
Aug 26, 2015 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Biological Chemistry
ISSN
1949-8454
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lumachi F, Santeufemia DA, Basso SM. Current medical treatment of estrogen receptor-positive breast cancer. World J Biol Chem 2015; 6(3): 231-239 [PMID: PMC4549764 DOI: 10.4331/wjbc.v6.i3.231] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v6/i3/231.htm |
| Number | Citing Articles |
| 1 |
Ya-Chi Chen, Jiajie Yu, Ciara Metcalfe, Tom De Bruyn, Thomas Gelzleichter, Vikram Malhi, Pablo D. Perez-Moreno, Xiaojing Wang. Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer. Expert Opinion on Investigational Drugs 2022; 31(6): 515 doi: 10.1080/13543784.2021.1983542
|
| 2 |
Engin Kut, Serkan Menekse. Retrospective Evaluation of Fulvestrant Efficacy and Clinical Results in Patients Using Fulvestrant. Cureus 2023; doi: 10.7759/cureus.35748
|
| 3 |
G S Hwang, R Bhat, R D Crutchley, M V Trivedi. Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes. The Pharmacogenomics Journal 2018; 18(2): 201 doi: 10.1038/tpj.2017.36
|
| 4 |
Wabel AL-Busairi, Maitham Khajah. Tumor Progression and Metastasis. 2020; doi: 10.5772/intechopen.86729
|
| 5 |
Nusrat Jan, Shazia Sofi, Hina Qayoom, Burhan Ul Haq, Aisha Shabir, Manzoor Ahmad Mir. Targeting breast cancer stem cells through retinoids: A new hope for treatment. Critical Reviews in Oncology/Hematology 2023; 192: 104156 doi: 10.1016/j.critrevonc.2023.104156
|
| 6 |
Aimee A. D’Aloisio, Hazel B. Nichols, M. Elizabeth Hodgson, Sandra L. Deming-Halverson, Dale P. Sandler. Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3686-6
|
| 7 |
Margaret A. Zimmerman, Rebecca A. Budish, Shreya Kashyap, Sarah H. Lindsey. GPER–novel membrane oestrogen receptor. Clinical Science 2016; 130(12): 1005 doi: 10.1042/CS20160114
|
| 8 |
Yuanqin Zhang, Xiangwei Fang, Jiuhui Wang, Daotai Nie. TMEM97/Sigma 2 Receptor Increases Estrogen Receptor α Activity in Promoting Breast Cancer Cell Growth. Cancers 2023; 15(23): 5691 doi: 10.3390/cancers15235691
|
| 9 |
Carlos Martínez-Campa, Javier Menéndez-Menéndez, Carolina Alonso-González, Alicia González, Virginia Álvarez-García, Samuel Cos. What is known about melatonin, chemotherapy and altered gene expression in breast cancer. Oncology Letters 2017; 13(4): 2003 doi: 10.3892/ol.2017.5712
|
| 10 |
Jie Xu, Cheol K. Chung, Andrew McClory, Kyle A. Mack, Michael E. Dalziel, Alec Fettes, Kyle Clagg, Ngiap-Kie Lim, Georg Wuitschik, Christian Jenny, Laure Finet, Michael Kammerer, Haiming Zhang, Rémy Angelaud, Francis Gosselin. Efficient Manufacturing Process for the Selective Estrogen Receptor Degrader GDC-9545 (Giredestrant) via a Crystallization-Driven Diastereoselective Pictet–Spengler Condensation. Organic Process Research & Development 2022; 26(3): 568 doi: 10.1021/acs.oprd.1c00263
|
| 11 |
Farzin Khosrow-Khavar, Nathaniel Bouganim, Kristian B Filion, Samy Suissa, Laurent Azoulay. Cardiotoxicity of Use of Sequential Aromatase Inhibitors in Women With Breast Cancer. American Journal of Epidemiology 2020; 189(10): 1086 doi: 10.1093/aje/kwaa065
|
| 12 |
Joshua P. Dignam, Smriti Sharma, Ioannis Stasinopoulos, Margaret R. MacLean. Pulmonary arterial hypertension: Sex matters. British Journal of Pharmacology 2024; 181(7): 938 doi: 10.1111/bph.16277
|
| 13 |
Antonella Ferro, Daniele Generali, Orazio Caffo, Alessia Caldara, Delia De Lisi, Mariachiara Dipasquale, Martina Lorenzi, Sara Monteverdi, Palma Fedele, Yari Ciribilli. Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?. Seminars in Oncology 2023; 50(3-5): 90 doi: 10.1053/j.seminoncol.2023.08.002
|
| 14 |
Keli He, Li Zhang, Xinghua Long. Quantitative assessment of the association between APC promoter methylation and breast cancer. Oncotarget 2016; 7(25): 37920 doi: 10.18632/oncotarget.9354
|
| 15 |
Yury V. Kuznetsov, Inna S. Levina, Alexander M. Scherbakov, Olga E. Andreeva, Irina V. Fedyushkina, Andrey S. Dmitrenok, Alexander S. Shashkov, Igor V. Zavarzin. New estrogen receptor antagonists. 3,20-Dihydroxy-19-norpregna-1,3,5(10)-trienes: Synthesis, molecular modeling, and biological evaluation. European Journal of Medicinal Chemistry 2018; 143: 670 doi: 10.1016/j.ejmech.2017.11.042
|
| 16 |
Amelie Heesch, Jochen Maurer, Elmar Stickeler, Mohsen Beheshti, Felix M. Mottaghy, Agnieszka Morgenroth. Development of Radiotracers for Breast Cancer—The Tumor Microenvironment as an Emerging Target. Cells 2020; 9(10): 2334 doi: 10.3390/cells9102334
|
| 17 |
Huseyin Beyaz, Hasan Uludag, Doga Kavaz, Nahit Rizaner. Cell Biology and Translational Medicine, Volume 14. Advances in Experimental Medicine and Biology 2021; 1347: 163 doi: 10.1007/5584_2021_648
|
| 18 |
Lauren D. Otto, Kathryn L. G. Russart, Praveen Kulkarni, Dana M. McTigue, Craig F. Ferris, Leah M. Pyter. Paclitaxel Chemotherapy Elicits Widespread Brain Anisotropy Changes in a Comprehensive Mouse Model of Breast Cancer Survivorship: Evidence From In Vivo Diffusion Weighted Imaging. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.798704
|
| 19 |
Di Fan, Hongbin Li, Xin Wang, Xueyuan Ling, Lin Ai. 68Ga-OncoFAP microPET/CT imaging in different breast cancer mouse models. Medicine Plus 2024; 1(3): 100044 doi: 10.1016/j.medp.2024.100044
|
| 20 |
Nicolas Carels, Lizânia Borges Spinassé, Tatiana Martins Tilli, Jack Adam Tuszynski. Toward precision medicine of breast cancer. Theoretical Biology and Medical Modelling 2016; 13(1) doi: 10.1186/s12976-016-0035-4
|
| 21 |
Chun-Yu Liu, Chia-Yun Wu, Karineh Petrossian, Tzu-Ting Huang, Ling-Ming Tseng, Shiuan Chen. Treatment for the endocrine resistant breast cancer: Current options and future perspectives. The Journal of Steroid Biochemistry and Molecular Biology 2017; 172: 166 doi: 10.1016/j.jsbmb.2017.07.001
|
| 22 |
Alexandru Filippi, Maria-Magdalena Mocanu. Mining TCGA Database for Genes with Prognostic Value in Breast Cancer. International Journal of Molecular Sciences 2023; 24(2): 1622 doi: 10.3390/ijms24021622
|
| 23 |
F. Khosrow-Khavar, H. Yin, A. Barkun, N. Bouganim, L. Azoulay. Aromatase inhibitors and the risk of colorectal cancer in postmenopausal women with breast cancer. Annals of Oncology 2018; 29(3): 744 doi: 10.1093/annonc/mdx822
|
| 24 |
Hala Attia, Afraa Alzoubi, Nour Al-anazi, Aliah Alshanwani, Naglaa El-Orabi, Alaa Alanteet, Raeesa Mohamad, Rehab Ali. Protective effects of cardamom aqueous extract against tamoxifen-induced pancreatic injury in female rats. Toxicological Research 2023; 39(4): 721 doi: 10.1007/s43188-023-00198-w
|
| 25 |
Antonella Ferro, Michela Campora, Alessia Caldara, Delia De Lisi, Martina Lorenzi, Sara Monteverdi, Raluca Mihai, Alessandra Bisio, Mariachiara Dipasquale, Orazio Caffo, Yari Ciribilli. Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine 2024; 13(12): 3611 doi: 10.3390/jcm13123611
|
| 26 |
Yu Zhong Peng, Li Jun Yang, Hang Hong Lo, Betty Yuen Kwan Law, Vincent Kam Wai Wong. New Nanomaterials and Techniques for Tumor-targeted Systems. 2020; : 135 doi: 10.1007/978-981-15-5159-8_6
|
| 27 |
Yu. V. Kuznetsov, I. S. Levina, A. S. Shashkov, I. V. Zavarzin. An efficient synthesis of 3-methoxy-19-norpregna-1,3,5(10),16-tetraen-20-one. Russian Chemical Bulletin 2018; 67(11): 2112 doi: 10.1007/s11172-018-2337-7
|
| 28 |
Vera Sorin, Eyal Klang, Miri Sklair-Levy, Israel Cohen, Douglas B. Zippel, Nora Balint Lahat, Eli Konen, Yiftach Barash. Large language model (ChatGPT) as a support tool for breast tumor board. npj Breast Cancer 2023; 9(1) doi: 10.1038/s41523-023-00557-8
|
| 29 |
Nora Jung, Veronique Maguer-Satta, Boris Guyot. Early Steps of Mammary Stem Cell Transformation by Exogenous Signals; Effects of Bisphenol Endocrine Disrupting Chemicals and Bone Morphogenetic Proteins. Cancers 2019; 11(9): 1351 doi: 10.3390/cancers11091351
|
| 30 |
Lokman Varisli, Garrett M. Dancik, Veysel Tolan, Spiros Vlahopoulos. Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target. Cancers 2023; 15(21): 5242 doi: 10.3390/cancers15215242
|
| 31 |
Sherko Kuemmel, Catherine Harper-Wynne, Yeon Hee Park, Fábio Franke, Michelino de Laurentiis, Eva Schumacher-Wulf, Daniel Eiger, Sarah Heeson, Andrés Cardona, Özgür Özyilkan, Flavia Morales-Vàsquez, Ciara Metcalfe, Marc Hafner, Eleonora Restuccia, Joyce O’Shaughnessy. heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12179-9
|
| 32 |
Michael K. McGrath, Ali Abolhassani, Luke Guy, Ahmed M. Elshazly, John T. Barrett, Nahid F. Mivechi, David A. Gewirtz, Patricia V. Schoenlein. Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1298423
|
| 33 |
Jie-Ning Li, Zhu-Jun Loh, Hui-Wen Chen, I-Ying Lee, Jui-Hung Tsai, Pai-Sheng Chen. SnoRNA U50A mediates everolimus resistance in breast cancer through mTOR downregulation. Translational Oncology 2024; 48: 102062 doi: 10.1016/j.tranon.2024.102062
|
| 34 |
Lindsay E. Calderon, Jonathan K. Keeling, Joseph Rollins, Carrie A. Black, Kendall Collins, Nova Arnold, Diane E. Vance, Margaret W. Ndinguri. Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor. Bioconjugate Chemistry 2017; 28(2): 461 doi: 10.1021/acs.bioconjchem.6b00610
|
| 35 |
Pedro Paulo Perroni da Silva, Ana Clara Salviato Capassi, Carolina Federicci Haddad, Larissa Araujo Santos, Marina Vieira Maia, Nadia Yumi Hatamoto, Luis Antonio Pires, Gilson Luchezi Delgado. Sexual quality of life in hormonotherapy for breast cancer patients. Brazilian Journal of Oncology 2022; 18(CP) doi: 10.5935/2526-8732.20220347
|
| 36 |
Shuangshuang Xiong, Ke Song, Hua Xiang, Guoshun Luo. Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer. European Journal of Medicinal Chemistry 2024; 270: 116393 doi: 10.1016/j.ejmech.2024.116393
|
| 37 |
Çağla KAYABAŞI, Çığır Biray AVCI, Sunde YILMAZ SÜSLÜER, Tuğçe BALCI OKCANOĞLU, Besra ÖZMEN YELKEN, Cansu ÇALIŞKAN KURT, Bakiye GÖKER BAĞCA, Cenk DURMUŞKAHYA, Hüsniye KAYALAR, Ahmet ÖZBİLGİN, Cumhur GÜNDÜZ. Ponatinib ve Türkiye’de yetişen bazı endemik bitki ekstrelerinin kombinasyonlarının meme kanseri hücreleri üzerindeki etkileri. Ege Tıp Dergisi 2022; 61(2): 232 doi: 10.19161/etd.1126901
|
| 38 |
Masriana Vivi Simanjuntak, Muhammad Miftah Jauhar, Putri Hawa Syaifie, Adzani Gaisani Arda, Etik Mardliyati, Wervyan Shalannanda, Beni Rio Hermanto, Isa Anshori. Revealing Propolis Potential Activity on Inhibiting Estrogen Receptor and Heat Shock Protein 90 Overexpressed in Breast Cancer by Bioinformatics Approaches. Bioinformatics and Biology Insights 2024; 18 doi: 10.1177/11779322231224187
|
| 39 |
Debbie Yancu, Rachel Viau, Thomas Sanderson. Development of an estrogen-dependent breast cancer co-culture model as a tool for studying endocrine disruptors. Toxicology in Vitro 2020; 62: 104658 doi: 10.1016/j.tiv.2019.104658
|
| 40 |
Hoon Kim, Wonshik Han, Seung-Yup Ku, Chang Suk Suh, Seok Hyun Kim, Young Min Choi. Feature of amenorrhea in postoperative tamoxifen users with breast cancer. Journal of Gynecologic Oncology 2017; 28(2) doi: 10.3802/jgo.2017.28.e10
|
| 41 |
Jie-Ning Li, Ming-Yang Wang, Yi-Ting Chen, Yao-Lung Kuo, Pai-Sheng Chen. Expression of SnoRNA U50A Is Associated with Better Prognosis and Prolonged Mitosis in Breast Cancer. Cancers 2021; 13(24): 6304 doi: 10.3390/cancers13246304
|
| 42 |
Imane Ait Oumghar, Abdelwahed Barkaoui, Patrick Chabrand, Abdellatif El Ghazi, Charlotte Jeanneau, Daphne Guenoun, Peter Pivonka. Experimental-based mechanobiological modeling of the anabolic and catabolic effects of breast cancer on bone remodeling. Biomechanics and Modeling in Mechanobiology 2022; 21(6): 1841 doi: 10.1007/s10237-022-01623-z
|
| 43 |
Brittany L. Witt, Trygve O. Tollefsbol. Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research. Life 2023; 13(12): 2311 doi: 10.3390/life13122311
|
| 44 |
Isabel Mayayo-Peralta, Beatrice Faggion, Liesbeth Hoekman, Ben Morris, Cor Lieftink, Isabella Goldsbrough, Lakjaya Buluwela, Joseph C. Siefert, Harm Post, Maarten Altelaar, Roderick Beijersbergen, Simak Ali, Wilbert Zwart, Stefan Prekovic. Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer. Cancers 2021; 13(24): 6314 doi: 10.3390/cancers13246314
|
| 45 |
Pegah Shakeri, S. Mohsen Asghari, Esmaeel Panahi Kokhdan, Vaezeh Fathi Vavsari, Farhad Golmohammadi, Alireza Ghassempour, Saeed Balalaie. Synthesis, molecular modeling and functional evaluation of a GnRH antagonist. Journal of the Iranian Chemical Society 2022; 19(7): 2705 doi: 10.1007/s13738-021-02484-6
|
| 46 |
Bo-Yu Lin, Sei-Ichiro Kamata, Mohammad Faizal Ahmad Fauzi, Wan Siti Halimatul Munirah Wan Ahmad. New Automatic Allred Scoring for Breast Cancer Nuclei Detection and Scoring from ER-IHC Stained Images. 2024 IEEE 8th International Conference on Signal and Image Processing Applications (ICSIPA) 2024; : 1 doi: 10.1109/ICSIPA62061.2024.10686193
|
| 47 |
Siew-Woh Choo, Yu Zhong, Edward Sendler, Anton-Scott Goustin, Juan Cai, Donghong Ju, Mary Ann Kosir, Roberta Giordo, Leonard Lipovich. Estrogen distinctly regulates transcription and translation of lncRNAs and pseudogenes in breast cancer cells. Genomics 2022; 114(4): 110421 doi: 10.1016/j.ygeno.2022.110421
|
| 48 |
Sara A Hurvitz, Aditya Bardia, Vanesa Quiroga, Yeon Hee Park, Isabel Blancas, José Luis Alonso-Romero, Aleksandr Vasiliev, Hryhoriy Adamchuk, Marcelo Salgado, Denise A Yardley, Oleksandr Berzoy, Pilar Zamora-Auñón, David Chan, Gonzalo Spera, Cloris Xue, Erika Ferreira, Tanja Badovinac Crnjevic, Pablo Diego Pérez-Moreno, Vanesa López-Valverde, Jutta Steinseifer, Tharu M Fernando, Heather M Moore, Peter A Fasching. Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study. The Lancet Oncology 2023; 24(9): 1029 doi: 10.1016/S1470-2045(23)00268-1
|
| 49 |
Yury V. Kuznetsov, Inna S. Levina, Alexander M. Scherbakov, Olga E. Andreeva, Andrey S. Dmitrenok, Oleg R. Malyshev, Igor V. Zavarzin. 3,20-Dihydroxy-13α-19-norpregna-1,3,5(10)-trienes. Synthesis, structures, and cytotoxic, estrogenic, and antiestrogenic effects. Steroids 2018; 137: 1 doi: 10.1016/j.steroids.2018.07.007
|
| 50 |
Tarek M. A. Abdel-Fatah, Graham R. Ball, Pulari U. Thangavelu, Lynne E. Reid, Amy E. McCart Reed, Jodi M. Saunus, Pascal H. G. Duijf, Peter T. Simpson, Sunil R. Lakhani, Lorinc Pongor, Balázs Gyorffy, Paul M. Moseley, Andrew R. Green, Alan G. Pockley, Carlos Caldas, Ian O. Ellis, Stephen Y. T. Chan. Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor–Positive Breast Cancer. JAMA Network Open 2020; 3(7): e209486 doi: 10.1001/jamanetworkopen.2020.9486
|
| 51 |
Carmen Ortiz-Sánchez, Jarline Encarnación-Medina, Ralphdy Vergne, Luis Padilla, Jaime Matta. Circulating Vitamin D Levels and DNA Repair Capacity in Four Molecular Subtypes of Women with Breast Cancer. International Journal of Molecular Sciences 2020; 21(18): 6880 doi: 10.3390/ijms21186880
|
| 52 |
Ruqaiyyah Siddiqui, Zinb Makhlouf, Ahmad M. Alharbi, Hasan Alfahemi, Naveed Ahmed Khan. The Gut Microbiome and Female Health. Biology 2022; 11(11): 1683 doi: 10.3390/biology11111683
|
| 53 |
Nikola Tanić, Tatjana Dramićanin, Nejla Ademović, Tijana Tomić, Blagoje Murganić, Zorka Milovanović, Milica Nedeljković, Nasta Tanić. The impact of TP53 and PTEN tumor suppressor genes on response to different breast cancer treatment modalities. Биомедицинска истраживања 2022; 13(2): 105 doi: 10.5937/BII2202105T
|
| 54 |
Anna Rose McGrorry, Amy Paterson, Nicola Peddie. The effects of exercise on sleep disturbances and cancer‐related fatigue for female breast cancer survivors receiving adjuvant hormone therapy: A systematic review. Lifestyle Medicine 2023; 4(4) doi: 10.1002/lim2.92
|
| 55 |
Majed Shtaiwi, Mohammad Alemleh, Kayed A. Abu-Safieh, Bader A. Salameh, Amneh Shtaiwi, Mohammad Alwahsh, Lama Hamadneh, Monther A. Khanfar. Design, Synthesis, Crystal Structure, Biological Activity and Molecular Modeling of Novel Schiff Bases Derived from Chalcones and 5-Hydrazino-1,3-Dimethyl-4-Nitropyrazole as Anticancer Agents. Polycyclic Aromatic Compounds 2024; 44(6): 4178 doi: 10.1080/10406638.2023.2247118
|
| 56 |
Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, Valéria Pereira Ferrer. Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: A breast cancer and glioblastoma view. Cytokine 2023; 170: 156344 doi: 10.1016/j.cyto.2023.156344
|
| 57 |
Rumeysa Ozyurt, Bulent Ozpolat. Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies. Cancers 2022; 14(21): 5206 doi: 10.3390/cancers14215206
|
| 58 |
Johannes Breyer, Ralph Markus Wirtz, Wolfgang Otto, Mark Laible, Kornelia Schlombs, Philipp Erben, Maximilian Christian Kriegmair, Robert Stoehr, Sebastian Eidt, Stefan Denzinger, Maximilian Burger, Arndt Hartmann. Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies. Oncotarget 2017; 8(40): 67684 doi: 10.18632/oncotarget.18804
|
| 59 |
Nadia Melillo, Francesco Paolo Cantatore. Breast cancer anti-hormonal therapy and rheumatic diseases: linking the clinical to molecular world. Beyond Rheumatology 2020; 2(1): 14 doi: 10.4081/br.2020.30
|
| 60 |
Yongmei Wang, Fanbo Jing, Haibo Wang. Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence. Advances in Therapy 2022; 39(2): 862 doi: 10.1007/s12325-021-01924-2
|
| 61 |
Juan P. Muñoz, Gloria M. Calaf. Acetylcholine, Another Factor in Breast Cancer. Biology 2023; 12(11): 1418 doi: 10.3390/biology12111418
|
| 62 |
Sneha Pandithar, Daniel Galke, Ahone Akume, Artem Belyakov, Dominick Lomonaco, Amirah A. Guerra, Jay Park, Olivia Reff, Kideok Jin. The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-023-09119-4
|
| 63 |
Salvador Flores-Torres, Tao Jiang, Jacqueline Kort-Mascort, Yun Yang, Omar Peza-Chavez, Sanjima Pal, Alisia Mainolfi, Lucas Antonio Pardo, Lorenzo Ferri, Nicholas Bertos, Veena Sangwan, Joseph M. Kinsella. Constructing 3D In Vitro Models of Heterocellular Solid Tumors and Stromal Tissues Using Extrusion-Based Bioprinting. ACS Biomaterials Science & Engineering 2023; 9(2): 542 doi: 10.1021/acsbiomaterials.2c00998
|
| 64 |
Virginia G. Kaklamani, William J. Gradishar. Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer. The Oncologist 2017; 22(5): 507 doi: 10.1634/theoncologist.2015-0464
|
| 65 |
Maria ACSM Borba, Renato P Melo-Neto, Glauber M Leitão, Carlos HM Castelletti, José L Lima-Filho, Danyelly BG Martins.
Evaluating the Impact of Missenses Mutations in
CYP2D6*7
and
CYP2D6*14A
: does it compromise Tamoxifen Metabolism?
. Pharmacogenomics 2016; 17(6): 561 doi: 10.2217/pgs-2015-0003
|
| 66 |
Xiao Cheng, Shiqi Hu, Ke Cheng. Microneedle Patch Delivery of PROTACs for Anti-Cancer Therapy. ACS Nano 2023; 17(12): 11855 doi: 10.1021/acsnano.3c03166
|
| 67 |
Xianghui Zou, Cesar Augusto Santa-Maria, Joseph O'Brien, David Gius, Yueming Zhu. Manganese Superoxide Dismutase Acetylation and Dysregulation, Due to Loss of SIRT3 Activity, Promote a Luminal B-Like Breast Carcinogenic-Permissive Phenotype. Antioxidants & Redox Signaling 2016; 25(6): 326 doi: 10.1089/ars.2016.6641
|
| 68 |
Zi-Rui Liang, Liang-Hu Qu, Li-Ming Ma. Differential impacts of charcoal-stripped fetal bovine serum on c-Myc among distinct subtypes of breast cancer cell lines. Biochemical and Biophysical Research Communications 2020; 526(1): 267 doi: 10.1016/j.bbrc.2020.03.049
|
| 69 |
Arpita Roy, Ashutosh Anand, Saksham Garg, Mohd Shahnawaz Khan, Sidharth Bhasin, Muhammad Nadeem Asghar, Talha Bin Emran, Ruchika Garg. Structure-Based In Silico Investigation of Agonists for Proteins Involved in Breast Cancer. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/7278731
|
| 70 |
Fatemeh Nasiri, Mehrasa Kazemi, Seyed Mohamad Javad Mirarefin, Maral Mahboubi Kancha, Milad Ahmadi Najafabadi, Faeze Salem, Setareh Dashti Shokoohi, Sahar Evazi Bakhshi, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani. CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1018786
|
| 71 |
Alana A Arnone, Katherine Ansley, Arielle L Heeke, Marissa Howard-McNatt, Katherine L Cook. Gut microbiota interact with breast cancer therapeutics to modulate efficacy. EMBO Molecular Medicine 2025; 17(2): 219 doi: 10.1038/s44321-024-00185-0
|
| 72 |
Shanshan Chen, Lan Bo, Dan Lv, Fei Ma. Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis. Breast Care 2022; 17(4): 391 doi: 10.1159/000523695
|
| 73 |
Takashi Takeshita, Hirotaka Iwase. Breast Cancer Treatment: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2024; 7: 303 doi: 10.1007/16833_2024_251
|
| 74 |
Md. Rizwanullah, Mohammad Zaki Ahmad, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Shadab Md, Nabil A. Alhakamy, Keerti Jain, Javed Ahmad. Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges. Pharmaceutics 2021; 13(12): 2039 doi: 10.3390/pharmaceutics13122039
|
| 75 |
Linda S. Steelman, Alberto M. Martelli, Lucio Cocco, Massimo Libra, Ferdinando Nicoletti, Stephen L. Abrams, James A. McCubrey. The therapeutic potential of mTOR inhibitors in breast cancer. British Journal of Clinical Pharmacology 2016; 82(5): 1189 doi: 10.1111/bcp.12958
|
| 76 |
Khairani Sukatendel, M. Fidel Ganis Siregar, Muharam Natadisastra, Iqbal Pahlevi Adiputra Nasution, Syafruddin Ilyas, M. Rhiza Tala, Putri Chairani Eyanoer, Poppy Anjelisa Z. Hasibuan. Benefits of Nigella sativa Extract Protecting Ovary Due to Cisplatin Chemotherapy. Open Access Macedonian Journal of Medical Sciences 2021; 9(A): 680 doi: 10.3889/oamjms.2021.6446
|
| 77 |
Sundee Dees, Rajkumar Ganesan, Sanjaya Singh, Iqbal S. Grewal. Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast Cancer. Molecular Cancer Therapeutics 2020; 19(12): 2409 doi: 10.1158/1535-7163.MCT-20-0385
|
| 78 |
Hanine Lattouf, Coralie Poulard, Isabelle Treilleux, Nader Hussein, Mona Diab-Assaf, Muriel Le Romancer. LKB1, A New Biomarker in Breast Cancer. Journal of Cancer Therapy 2016; 7(10): 690 doi: 10.4236/jct.2016.710071
|
| 79 |
Lalitha Vaishnavi Subramanyan, Suhail Ahmed Kabeer Rasheed, Lijin Wang, Sujoy Ghosh, Michelle Shi Ning Ong, Manikandan Lakshmanan, Mei Wang, Patrick J. Casey. GNA13 suppresses proliferation of ER+ breast cancer cells via ERα dependent upregulation of the MYC oncogene. Breast Cancer Research 2024; 26(1) doi: 10.1186/s13058-024-01866-x
|
| 80 |
Tao Yu, Hai-Ru Yu, Jia-Yi Sun, Zhao Zhao, Shuang Li, Xin-Feng Zhang, Zhi-Xuan Liao, Ming-Ke Cui, Juan Li, Chan Li, Qiang Zhang. miR-1271 inhibits ERα expression and confers letrozole resistance in breast cancer. Oncotarget 2017; 8(63): 107134 doi: 10.18632/oncotarget.22359
|
| 81 |
Grace S. Hwang, Rutugandha Paranjpe, Carine Opsomer, Kelvin Lu, Uzoamaka Abajue, Susan Abughosh, Hanna Zaghloul, Meghana V. Trivedi. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution. Clinical Breast Cancer 2020; 20(6): 520 doi: 10.1016/j.clbc.2020.06.004
|
| 82 |
Archita Goyal, Gabrielle E. Milner, Ashley Cimino-Mathews, Kala Visvanathan, Antonio C. Wolff, Dipali Sharma, Jennifer Y. Sheng. Weight Gain after Hormone Receptor-Positive Breast Cancer. Current Oncology 2022; 29(6): 4090 doi: 10.3390/curroncol29060326
|
| 83 |
Niraj Neupane, Sawyer Bawek, Sayuri Gurusinghe, Elham Moases Ghaffary, Omid Mirmosayyeb, Sangharsha Thapa, Carla Falkson, Ruth O’Regan, Ajay Dhakal. Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer. Cancers 2024; 16(3): 619 doi: 10.3390/cancers16030619
|
| 84 |
M. O. Tserfas, Yu. V. Kuznetsov, V. V. Knyazev, I. S. Levina, I. V. Zavarzin. Key structures in the synthesis of steroid antitumor agents. Methods for upbuilding the 17β-pregnane side chain of 3-methoxy-19-norpregna-1,3,5(10)-trien-20-ones with and without an additional 16α,17α-carbocycle. Russian Chemical Bulletin 2022; 71(8): 1806 doi: 10.1007/s11172-022-3593-0
|
| 85 |
Hongjin Li, Susan M. Sereika, Anna L. Marsland, Yvette P. Conley, Catherine M. Bender. Symptom Clusters in Women With Breast Cancer During the First 18 Months of Adjuvant Therapy. Journal of Pain and Symptom Management 2020; 59(2): 233 doi: 10.1016/j.jpainsymman.2019.10.002
|
| 86 |
Mengyao Wu, Yilan Zhao, Chi Zhang, Kanyi Pu. Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment. ACS Nano 2024; 18(42): 28502 doi: 10.1021/acsnano.4c09800
|
| 87 |
Peng Xing, Huiting Dong, Qun Liu, Fan Yao, Yingying Xu, Bo Chen, Xinyu Zheng, Yunfei Wu, Feng Jin, Jiguang Li. Impact of persistence on survival of patients with breast cancer treated with endocrine therapy in Northeast China: a prospective study. Oncotarget 2017; 8(60): 102499 doi: 10.18632/oncotarget.18454
|
| 88 |
Marilena Antunes-Ricardo, Javier Villela-Castrejón, Janet A. Gutiérrez-Uribe, Sergio O. Serna Saldívar. Science and Technology of Fibers in Food Systems. Food Engineering Series 2020; : 241 doi: 10.1007/978-3-030-38654-2_11
|
| 89 |
Muchtaridi Muchtaridi, Muhammmad Jajuli, Muhammad Yusuf. Antagonistic Mechanism of Chalcone Derivatives Against Human Estrogen Alpha of Breast Cancer Using Molecular Dynamic Simulation. Oriental Journal of Chemistry 2018; 34(6): 2735 doi: 10.13005/ojc/340607
|
| 90 |
Perwez Alam, Pradeep Sharma, Mohammed Faiz Arshad. Comprehensive Computational Screening and Analysis of Natural Compounds Reveals Promising Estrogen Receptor Alpha Inhibitors for Breast Cancer Therapy. Chemistry & Biodiversity 2025; 22(2) doi: 10.1002/cbdv.202402052
|
| 91 |
Laura A Baker, Holly Holliday, Alexander Swarbrick. ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer. Endocrine-Related Cancer 2016; 23(9): R381 doi: 10.1530/ERC-16-0196
|
| 92 |
Farzin Khosrow‐Khavar, Laurent Azoulay, Jean‐Louis Montastruc, François Montastruc, Christel Renoux. Aromatase inhibitors and the incidence of Parkinson disease: A population‐based cohort study. Cancer 2022; 128(12): 2339 doi: 10.1002/cncr.34208
|
| 93 |
Jamie V. Shiah, Daniel E. Johnson, Jennifer R. Grandis. Transcription Factors and Cancer. The Cancer Journal 2023; 29(1): 38 doi: 10.1097/PPO.0000000000000639
|
| 94 |
Koch Visser, Oliver Zierau, Dana Macejová, Florian Goerl, Michael Muders, Gustavo B. Baretton, Günter Vollmer, Ann Louw. The phytoestrogenic Cyclopia extract, SM6Met, increases median tumor free survival and reduces tumor mass and volume in chemically induced rat mammary gland carcinogenesis. The Journal of Steroid Biochemistry and Molecular Biology 2016; 163: 129 doi: 10.1016/j.jsbmb.2016.04.019
|
| 95 |
Liming Ma, Zirui Liang, Hui Zhou, Lianghu Qu. Applications of RNA Indexes for Precision Oncology in Breast Cancer. Genomics, Proteomics & Bioinformatics 2018; 16(2): 108 doi: 10.1016/j.gpb.2018.03.002
|
| 96 |
Wei-Yun Guo, Shang-Ming-Zhu Zeng, Girdhar Singh Deora, Qing-Shan Li, Ban-Feng Ruan. Estrogen Receptor α (ERα)-targeting Compounds and Derivatives: Recent Advances in Structural Modification and Bioactivity. Current Topics in Medicinal Chemistry 2019; 19(15): 1318 doi: 10.2174/1568026619666190619142504
|
| 97 |
Yitian Lang, Qingqing Chai, Yan Lin, Bin Wu, Xiaoyan Liu. Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis. Frontiers in Pharmacology 2025; 15 doi: 10.3389/fphar.2024.1495082
|
| 98 |
Xin Song, Chun-Yu Lin, Xueting Mei, Liyun Wang, Lidan You. Reduction of breast cancer extravasation via vibration activated osteocyte regulation. iScience 2022; 25(12): 105500 doi: 10.1016/j.isci.2022.105500
|
| 99 |
ZEINAB KLAAB, AZIZA HASSAN, JAWAHER ALBAQAMI, FAIZAH A. ALMALKI. The effect of natural products combination on MCF-7 cells exceeds tamoxifen therapeutic dose effects in vitro. BIOCELL 2023; 47(4): 891 doi: 10.32604/biocell.2023.026556
|
| 100 |
Yeong-Seon Won, Kwon-Il Seo. Lupiwighteone induces caspase-dependent and -independent apoptosis on human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway. Food and Chemical Toxicology 2020; 135: 110863 doi: 10.1016/j.fct.2019.110863
|
| 101 |
|
| 102 |
Hyung-Jin Lim, Jaehoon Bae, Seon-Gyeong Bak, Nisansala Chandimali, Eun Hyun Park, Sang-Ik Park, Hirofumi Tachibana, Yeong-Seon Won, Seung-Jae Lee. Limocitrin Suppresses Breast Cancer Through Inducing Apoptotic-Cell Death Signaling and Inhibiting the PI3K/AKT/mTOR/S6K Cell Survival Signaling. Journal of Medicinal Food 2023; 26(10): 749 doi: 10.1089/jmf.2023.K.0117
|
| 103 |
Fernanda Cardoso da Silva, Douglas Cardoso Brandão, Everton Allan Ferreira, Raoni Pais Siqueira, Helen Soares Valença Ferreira, Ademar Alves Da Silva Filho, Thaise Gonçalves Araújo. Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer. Pharmaceuticals 2023; 16(10): 1466 doi: 10.3390/ph16101466
|
| 104 |
Mohamed Gaber, Alana A. Arnone, Pierre-Alexandre Vidi, Katherine L. Cook. The microbiome: a link between obesity and breast cancer risk. Frontiers in Microbiomes 2024; 3 doi: 10.3389/frmbi.2024.1394719
|
| 105 |
Ren Guanghui, Hao Xiaoyan, Yang Shuyi, Chen Jun, Qiu Guobin. An efficient or methodical review of immunotherapy against breast cancer. Journal of Biochemical and Molecular Toxicology 2019; 33(8) doi: 10.1002/jbt.22339
|
| 106 |
Payal Kesharwani, Shiv Kumar Prajapati, Ankit Jain, Nishi Mody, Swapnil Sharma. Polymeric Biomaterials for Healthcare Applications. 2022; : 211 doi: 10.1016/B978-0-323-85233-3.00006-9
|
| 107 |
Mª Jesús Núñez-Iglesias, Silvia Novio, Carlota García, Mª Elena Pérez-Muñuzuri, María-Carmen Martínez, José-Luis Santiago, Susana Boso, Pilar Gago, Manuel Freire-Garabal. Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro. International Journal of Molecular Sciences 2021; 22(13): 7178 doi: 10.3390/ijms22137178
|
| 108 |
Milad Rouhimoghadam, Anh S. Lu, Aliasger K. Salem, Edward J. Filardo. Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.591217
|
| 109 |
Hanggara Arifian, Rani Maharani, Sandra Megantara, Nur Kusaira Khairul Ikram, Muchtaridi Muchtaridi. Glycine-Conjugated α-Mangostins as Potential Estrogen Receptor Alpha (ERα) Antagonists through Pharmacophore Modeling, Docking Analysis, and Molecular Dynamics Simulations. Applied Sciences 2024; 14(13): 5549 doi: 10.3390/app14135549
|
| 110 |
Sunita Nilkhet, Wudtipong Vongthip, Pattawika Lertpatipanpong, Anchalee Prasansuklab, Tewin Tencomnao, Siriporn Chuchawankul, Seung Joon Baek. Ergosterol inhibits the proliferation of breast cancer cells by suppressing AKT/GSK-3beta/beta-catenin pathway. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70516-1
|
| 111 |
Anwar Shams. Impact of prolactin treatment on enhancing the cellular responses of MCF7 breast cancer cells to tamoxifen treatment. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01701-x
|
| 112 |
Sheng-Fan Wang, Yuh-Lih Chang, Yen-Dun Tzeng, Chun-Ling Wu, Yuan-Zhong Wang, Ling-Ming Tseng, Shiuan Chen, Hsin-Chen Lee. Mitochondrial stress adaptation promotes resistance to aromatase inhibitor in human breast cancer cells via ROS/calcium up-regulated amphiregulin–estrogen receptor loop signaling. Cancer Letters 2021; 523: 82 doi: 10.1016/j.canlet.2021.09.043
|
| 113 |
Manouchehr Aghajanzadeh, Hossein Torabi, Behrouz Najafi, Pedram Talebi, Kasra Shirini. Intermammary breast cancer: A rare case of cancer with origin of breast cells in an unusual location. SAGE Open Medical Case Reports 2023; 11 doi: 10.1177/2050313X231154996
|
| 114 |
Kevin Yao, Evelien Schaafsma, Baoyi Zhang, Chao Cheng, Feng Fu. Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer. PLOS Computational Biology 2022; 18(3): e1009495 doi: 10.1371/journal.pcbi.1009495
|
| 115 |
Sravanthi Cheeti, Hao Helen Hou, Eric Nelson, Helen Walker, Buyun Chen, Roland Morley, Mary Gates, Luna Musib, Sandhya Girish, Srikumar Sahasranaman, Lichuan Liu. Application of a Novel ‘Make and Test in Parallel’ Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects. Pharmaceutical Research 2018; 35(12) doi: 10.1007/s11095-018-2516-0
|
| 116 |
Dorine de Jong, Elise Desperito, Karine Al Feghali, Laurent Dercle, Romain-David Seban, Jeeban Das, Hong Ma, Abin Sajan, Brian Braumuller, Conor Prendergast, Connie Liou, Aileen Deng, Tina Roa, Randy Yeh, Antoine Girard, Mary Salvatore, Kathleen Capaccione. Advances in PET/CT Imaging for Breast Cancer. Journal of Clinical Medicine 2023; 12(13): 4537 doi: 10.3390/jcm12134537
|
| 117 |
Wen‐Jing Liu, Gang Zhao, Chen‐Yan Zhang, Chang‐Qing Yang, Xiang‐Bin Zeng, Jin Li, Kun Zhu, Shi‐Qi Zhao, Hui‐Meng Lu, Da‐Chuan Yin, Sheng‐Xiang Lin. Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer. Journal of Cellular Biochemistry 2020; 121(4): 2756 doi: 10.1002/jcb.29515
|
| 118 |
Ozge Saatci, Kim-Tuyen Huynh-Dam, Ozgur Sahin. Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies. Journal of Molecular Medicine 2021; 99(12): 1691 doi: 10.1007/s00109-021-02136-5
|
| 119 |
Gi Dae Kim. Ursolic Acid Decreases the Proliferation of MCF-7 Cell-Derived Breast Cancer Stem-Like Cells by Modulating the ERK and PI3K/AKT Signaling Pathways. Preventive Nutrition and Food Science 2021; 26(4): 434 doi: 10.3746/pnf.2021.26.4.434
|
| 120 |
Leseho Swana, Bienvenu Tsakem, Jacqueline V. Tembu, Rémy B. Teponno, Joy T. Folahan, Jarmo-Charles Kalinski, Alexandros Polyzois, Guy Kamatou, Louis P. Sandjo, Jean Christopher Chamcheu, Xavier Siwe-Noundou. The Genus Dacryodes Vahl.: Ethnobotany, Phytochemistry and Biological Activities. Pharmaceuticals 2023; 16(5): 775 doi: 10.3390/ph16050775
|
| 121 |
Shweta Satpathi, Sagar S Gaurkar, Ashwini Potdukhe, Mayur B Wanjari. Unveiling the Role of Hormonal Imbalance in Breast Cancer Development: A Comprehensive Review. Cureus 2023; doi: 10.7759/cureus.41737
|
| 122 |
Çağla KAYABAŞI, Sunde YILMAZ SÜSLÜER, Tuğçe BALCI OKCANOĞLU, Besra ÖZMEN YELKEN, Zeynep MUTLU, Cansu ÇALIŞKAN KURT, Bakiye GOKER BAGCA, Çığır BİRAY AVCI, Cumhur GÜNDÜZ. Ponatinib miRNA İfadelerini Düzenleyerek Meme Kanseri Hücrelerini Hedefler. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2021; 47(3): 365 doi: 10.32708/uutfd.1002443
|
| 123 |
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, Biswajit Swain, Diksha Malhotra, Suryendu Saha, Sinjan Khanra, Priyanka Mishra, Sambhunath Majhi, Kavita Kumari, Angitha N. Nath, Swarnali Saha, Sarmistha Jena, Gopal C. Kundu. Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review. Cancers 2025; 17(2): 234 doi: 10.3390/cancers17020234
|
| 124 |
Bharti Mangla, Ozair Alam, Rehan Abdur Rub, Muzaffar Iqbal, Archu Singh, Kuldeep Singh Patel, Kanchan Kohli. Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an oral pharmacokinetic study. Journal of Chromatography B 2020; 1152: 122260 doi: 10.1016/j.jchromb.2020.122260
|
| 125 |
Nayara de Souza da Costa, Luíza Siqueira Lima, Maria Eduarda Andrade Galiciolli, Deborah Helen Fabiano Ribeiro, Milena Mariano Ribeiro, Gisele de Paula Júlia Garica, Isabela Saragioto Marçal, Juliana Ferreira da Silva, Meire Ellen Pereira, Cláudia Sirlene Oliveira, Izonete Cristina Guiloski. Drug-induced osteoporosis and mechanisms of bone tissue regeneration through trace elements. Journal of Trace Elements in Medicine and Biology 2024; 84: 127446 doi: 10.1016/j.jtemb.2024.127446
|
| 126 |
Margaret F. Bedillion, Emily B. Ansell, Gwendolyn A. Thomas. Cancer treatment effects on cognition and depression: The moderating role of physical activity. The Breast 2019; 44: 73 doi: 10.1016/j.breast.2019.01.004
|
| 127 |
Yu Xie, Meihua Shan, Jing Yu, Yongjun Du, Chengkun Wu, Shujing Liu, Jiayin Li, Yupeng Xiao, Yan Yan, Ning Li, Junfang Qin, Lan Lan, Yue Wang. LINC00173 silence and estrone supply suppress ER+ breast cancer by estrogen receptor α degradation and LITAF activation. Cancer Science 2024; 115(7): 2318 doi: 10.1111/cas.16201
|
| 128 |
Sagir ISMAİL, Adamu UZAİRU, Balarabe SAGAGİ, Muhd Sabiu SULEİMAN. Insilico Molecular Docking and Pharmacokinetic Studies of Selected Phytochemicals With Estrogen and Progesterone Receptors as Anticancer Agent for Breast Cancer. Journal of the Turkish Chemical Society Section A: Chemistry 2018; 5(3): 1337 doi: 10.18596/jotcsa.449778
|
| 129 |
Meenakshi Sudhakaran, Sagar Sardesai, Andrea I. Doseff. Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer Control. Antioxidants 2019; 8(4): 103 doi: 10.3390/antiox8040103
|
| 130 |
Xi Zhang, Nadia Harbeck, Udo Jeschke, Sophie Doisneau-Sixou. Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer. Journal of Cancer Research and Clinical Oncology 2017; 143(7): 1107 doi: 10.1007/s00432-016-2325-y
|
| 131 |
Sheng-Fan Wang, Yi-Sheng Lin, Wan-Yu Yeh, Yuh-Lih Chang, Chern-En Chiang, Chen-Huan Chen, Ling-Ming Tseng, Hsin-Chen Lee, Chun-Yu Liu, Hao-Min Cheng. The Clinical Benefits of Antiresorptive Agents in Patients with Primary Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review with Pairwise and Network Meta-analysis. The Journal of Clinical Endocrinology & Metabolism 2023; 108(11): e1433 doi: 10.1210/clinem/dgad247
|
| 132 |
Chae Won Ock, Gi Dae Kim. Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling Pathways. Molecules 2021; 26(21): 6714 doi: 10.3390/molecules26216714
|
| 133 |
AbuSamra Nehal, Rashad Mona, Abd ElMoneim Nadia, Shawky Sanaa, Kamel Maher. The prognostic value of vitamin D receptor and its up-stream miR-27b and miR-125a expression in breast cancer patients. Gene Reports 2021; 23: 101121 doi: 10.1016/j.genrep.2021.101121
|
| 134 |
Farah J Nassar, Rihab Nasr, Rabih Talhouk. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction. Pharmacology & Therapeutics 2017; 172: 34 doi: 10.1016/j.pharmthera.2016.11.012
|
| 135 |
Prarthana Chatterjee, Suchetana Gupta, Satarupa Banerjee. Recent Frontiers of Phytochemicals. 2023; : 261 doi: 10.1016/B978-0-443-19143-5.00004-9
|
| 136 |
Komal L. Jhaveri, Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni, Joohyuk Sohn, Tomas G. Neilan, Rafael Villanueva-Vázquez, Peter Kabos, Laura García-Estévez, Elena López-Miranda, J. Alejandro Pérez-Fidalgo, Jose M. Pérez-García, Jiajie Yu, Jill Fredrickson, Heather M. Moore, Ching-Wei Chang, John W. Bond, Jennifer Eng-Wong, Mary R. Gates, Elgene Lim. Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer. Clinical Cancer Research 2024; 30(4): 754 doi: 10.1158/1078-0432.CCR-23-1796
|
| 137 |
Gary J. Cheng, Euphemia Y. Leung, Dean C. Singleton. In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy. Exploration of Targeted Anti-tumor Therapy 2022; : 297 doi: 10.37349/etat.2022.00084
|
| 138 |
Lisa M. Lang, Christian Behr, Marion Ludwig, Jochen Walker, Hans Christian Lange, Frederike Basedow, Christina Justenhoven. Routine practice data of three cancer entities: Comparison among cancer registry and health insurance data. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2023; 177: 65 doi: 10.1016/j.zefq.2023.01.001
|
| 139 |
Mithila Sawant, Audrey Wilson, Dhivya Sridaran, Kiran Mahajan, Christopher J. O’Conor, Ian S. Hagemann, Jingqin Luo, Cody Weimholt, Tiandao Li, Juan Carlos Roa, Akhilesh Pandey, Xinyan Wu, Nupam P. Mahajan. Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor. Oncogene 2023; 42(29): 2263 doi: 10.1038/s41388-023-02747-x
|
| 140 |
Manzoor Ahmad Mir, Ulfat Jan. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. 2023; : 211 doi: 10.1007/978-981-19-8911-7_10
|
| 141 |
Regan Odongo, Asuman Demiroglu-Zergeroglu, Tunahan Çakır. A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer. BioData Mining 2024; 17(1) doi: 10.1186/s13040-024-00357-1
|
| 142 |
Keva Li, Manjeet Chadha, Erin Moshier, Barry S. Rosenstein, Harkeran K. Jandu, Colin D. Veal, Laura Fachal, Craig Luccarini, Miguel E. Aguado-Barrera, Manuel Altabas, David Azria, Adinda Baten, Celine Bourgier, Renée Bultijnck, Riccardo R. Colciago, Marie-Pierre Farcy-Jacquet, Jenny Chang-Claude, Ananya Choudhury, Alison Dunning, Rebecca M. Elliott, Sheryl Green, Sara Gutiérrez-Enríquez, Carsten Herskind, Maarten Lambrecht, Christel Monten, Tiziana Rancati, Victoria Reyes, Dirk De Ruysscher, Maria Carmen De Santis, Petra Seibold, Elena Sperk, Marlon R. Veldwijk, R. Paul Symonds, Hilary Stobart, Begoña Taboada-Valladares, Ana Vega, Liv Veldeman, Adam J. Webb, Caroline Weltens, Catharine M. West, Tim Rattay, Christopher J. Talbot. Age-stratified analysis of health-related quality of life in patients with early-stage breast cancer receiving adjuvant radiation therapy and endocrine therapy. Journal of Geriatric Oncology 2025; 16(2): 102195 doi: 10.1016/j.jgo.2025.102195
|
| 143 |
Bernice Monchusi, Mandeep Kaur. microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance. Genes & Cancer 2020; 11(1-2): 20 doi: 10.18632/genesandcancer.202
|
| 144 |
Omolola R. Oyenihi, Annadie Krygsman, Nicolette Verhoog, Dalene de Beer, Michael J. Saayman, Thys M. Mouton, Ann Louw. Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia Extract. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00650
|
| 145 |
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies, Rajesh Singh. Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer. Cancers 2023; 15(4): 1320 doi: 10.3390/cancers15041320
|
| 146 |
Silvia Gobbi, Silvia Martini, Riccardo Rozza, Angelo Spinello, Jessica Caciolla, Angela Rampa, Federica Belluti, Nadia Zaffaroni, Alessandra Magistrato, Alessandra Bisi. Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment. Molecules 2023; 28(7): 3047 doi: 10.3390/molecules28073047
|
| 147 |
MATH: A Deep Learning Approach in QSAR for Estrogen Receptor Alpha Inhibitors. Molecules 2023; 28(15): 5843 doi: 10.3390/molecules28155843
|